Logo image of EUZ.DE

ECKERT & ZIEGLER SE (EUZ.DE) Stock Overview

Europe - FRA:EUZ - DE0005659700 - Common Stock

18.33 EUR
+0.33 (+1.83%)
Last: 9/19/2025, 7:00:00 PM

EUZ.DE Key Statistics, Chart & Performance

Key Statistics
52 Week High34.88
52 Week Low16.27
Market Cap1.16B
Shares63.52M
Float42.75M
Yearly Dividend0.02
Dividend Yield0.93%
EPS(TTM)0.59
PE31.07
Fwd PE19.91
Earnings (Next)11-13 2025-11-13
IPO05-25 1999-05-25
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


EUZ.DE short term performance overview.The bars show the price performance of EUZ.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30 -40

EUZ.DE long term performance overview.The bars show the price performance of EUZ.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 5 -5 10 -10 -15

The current stock price of EUZ.DE is 18.33 EUR. In the past month the price increased by 4.8%. In the past year, price decreased by -15.57%.

ECKERT & ZIEGLER SE / EUZ Daily stock chart

EUZ.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABL.DE ABBOTT LABORATORIES 27.8 200.81B
IUI1.DE INTUITIVE SURGICAL INC 54.5 133.05B
BSX.DE BOSTON SCIENTIFIC CORP 34.73 122.99B
2M6.DE MEDTRONIC PLC 17.19 103.17B
SHL.DE SIEMENS HEALTHINEERS AG 19.81 53.19B
BOX.DE BECTON DICKINSON AND CO 13.14 45.47B
EWL.DE EDWARDS LIFESCIENCES CORP 29.1 37.07B
1RMD.MI RESMED INC 28.58 33.81B
1PHIA.MI KONINKLIJKE PHILIPS NV 16.68 23.13B
DC4.DE DEXCOM INC 40.93 23.11B
PHIA.AS KONINKLIJKE PHILIPS NV 16.57 22.98B
PHI1.DE KONINKLIJKE PHILIPS NV 16.57 22.98B

About EUZ.DE

Company Profile

EUZ logo image Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,098 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Company Info

ECKERT & ZIEGLER SE

Robert-Roessle-Str.10

Berlin BERLIN DE

Employees: 1085

EUZ Company Website

EUZ Investor Relations

Phone: 49309410840

ECKERT & ZIEGLER SE / EUZ.DE FAQ

What is the stock price of ECKERT & ZIEGLER SE today?

The current stock price of EUZ.DE is 18.33 EUR. The price increased by 1.83% in the last trading session.


What is the ticker symbol for ECKERT & ZIEGLER SE stock?

The exchange symbol of ECKERT & ZIEGLER SE is EUZ and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is EUZ.DE stock listed?

EUZ.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for ECKERT & ZIEGLER SE stock?

6 analysts have analysed EUZ.DE and the average price target is 22.9 EUR. This implies a price increase of 24.96% is expected in the next year compared to the current price of 18.33. Check the ECKERT & ZIEGLER SE stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ECKERT & ZIEGLER SE worth?

ECKERT & ZIEGLER SE (EUZ.DE) has a market capitalization of 1.16B EUR. This makes EUZ.DE a Small Cap stock.


How many employees does ECKERT & ZIEGLER SE have?

ECKERT & ZIEGLER SE (EUZ.DE) currently has 1085 employees.


What are the support and resistance levels for ECKERT & ZIEGLER SE (EUZ.DE) stock?

ECKERT & ZIEGLER SE (EUZ.DE) has a support level at 16.3 and a resistance level at 18.34. Check the full technical report for a detailed analysis of EUZ.DE support and resistance levels.


Is ECKERT & ZIEGLER SE (EUZ.DE) expected to grow?

The Revenue of ECKERT & ZIEGLER SE (EUZ.DE) is expected to grow by 8.76% in the next year. Check the estimates tab for more information on the EUZ.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ECKERT & ZIEGLER SE (EUZ.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ECKERT & ZIEGLER SE (EUZ.DE) stock pay dividends?

ECKERT & ZIEGLER SE (EUZ.DE) has a dividend yield of 0.93%. The yearly dividend amount is currently 0.02. Check the full fundamental report for a detailed analysis of EUZ.DE dividend history, reliability and sustainability.


When does ECKERT & ZIEGLER SE (EUZ.DE) report earnings?

ECKERT & ZIEGLER SE (EUZ.DE) will report earnings on 2025-11-13.


What is the Price/Earnings (PE) ratio of ECKERT & ZIEGLER SE (EUZ.DE)?

The PE ratio for ECKERT & ZIEGLER SE (EUZ.DE) is 31.07. This is based on the reported non-GAAP earnings per share of 0.59 and the current share price of 18.33 EUR. Check the full fundamental report for a full analysis of the valuation metrics for EUZ.DE.


EUZ.DE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to EUZ.DE. When comparing the yearly performance of all stocks, EUZ.DE is a bad performer in the overall market: 96.38% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

EUZ.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE. EUZ.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EUZ.DE Financial Highlights

Over the last trailing twelve months EUZ.DE reported a non-GAAP Earnings per Share(EPS) of 0.59. The EPS increased by 16.02% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.24%
ROA 8.35%
ROE 16.32%
Debt/Equity 0.18
Chartmill High Growth Momentum
EPS Q2Q%24.4%
Sales Q2Q%3.66%
EPS 1Y (TTM)16.02%
Revenue 1Y (TTM)9.42%

EUZ.DE Forecast & Estimates

6 analysts have analysed EUZ.DE and the average price target is 22.9 EUR. This implies a price increase of 24.96% is expected in the next year compared to the current price of 18.33.

For the next year, analysts expect an EPS growth of 33.97% and a revenue growth 8.76% for EUZ.DE


Analysts
Analysts80
Price Target22.9 (24.93%)
EPS Next Y33.97%
Revenue Next Year8.76%

EUZ.DE Ownership

Ownership
Inst Owners25.96%
Ins Owners0.23%
Short Float %N/A
Short RatioN/A